PREDICT SPA (PRE.MI) Fundamental Analysis & Valuation

BIT:PRE • IT0005611071

Current stock price

0.78 EUR
-0.05 (-6.59%)
Last:

This PRE.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PRE.MI Profitability Analysis

1.1 Basic Checks

  • PRE had positive earnings in the past year.
PRE.MI Yearly Net Income VS EBIT VS OCF VS FCFPRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

  • With an excellent Return On Assets value of 7.11%, PRE belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
  • The Return On Equity of PRE (16.48%) is better than 89.29% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.60%, PRE belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROIC 14.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRE.MI Yearly ROA, ROE, ROICPRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6

1.3 Margins

  • The Profit Margin of PRE (5.07%) is better than 78.57% of its industry peers.
  • PRE has a better Operating Margin (7.76%) than 64.29% of its industry peers.
  • Looking at the Gross Margin, with a value of 20.96%, PRE is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PRE.MI Yearly Profit, Operating, Gross MarginsPRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRE.MI Health Analysis

2.1 Basic Checks

  • PRE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • PRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRE.MI Yearly Shares OutstandingPRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
PRE.MI Yearly Total Debt VS Total AssetsPRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

  • An Altman-Z score of 3.47 indicates that PRE is not in any danger for bankruptcy at the moment.
  • PRE's Altman-Z score of 3.47 is amongst the best of the industry. PRE outperforms 92.86% of its industry peers.
  • There is no outstanding debt for PRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.47
ROIC/WACC1.93
WACC7.57%
PRE.MI Yearly LT Debt VS Equity VS FCFPRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M

2.3 Liquidity

  • PRE has a Current Ratio of 1.27. This is a normal value and indicates that PRE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, PRE is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • A Quick Ratio of 0.90 indicates that PRE may have some problems paying its short term obligations.
  • The Quick ratio of PRE (0.90) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.9
PRE.MI Yearly Current Assets VS Current LiabilitesPRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. PRE.MI Growth Analysis

3.1 Past

  • PRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.14%, which is quite impressive.
  • PRE shows a decrease in Revenue. In the last year, the revenue decreased by -7.84%.
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRE.MI Yearly Revenue VS EstimatesPRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

More info and screens

Find the best growth stocksShow best growing peers

2

4. PRE.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.00, PRE is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of PRE indicates a somewhat cheap valuation: PRE is cheaper than 71.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.89, PRE is valued rather cheaply.
Industry RankSector Rank
PE 13
Fwd PE N/A
PRE.MI Price Earnings VS Forward Price EarningsPRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRE.MI Per share dataPRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PRE.MI Dividend Analysis

5.1 Amount

  • PRE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRE.MI Fundamentals: All Metrics, Ratios and Statistics

PREDICT SPA

BIT:PRE (4/16/2026, 7:00:00 PM)

0.78

-0.05 (-6.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.34M
Revenue(TTM)6.63M
Net Income(TTM)336.00K
Analysts80
Price Target1.94 (148.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 2.13
P/tB 2.69
EV/EBITDA N/A
EPS(TTM)0.06
EY7.69%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.19
BVpS0.37
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.703057 (-9.86%)
Profitability
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROCE 21.65%
ROIC 14.6%
ROICexc 16.05%
ROICexgc 19.99%
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.9
Altman-Z 3.47
F-ScoreN/A
WACC7.57%
ROIC/WACC1.93
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PREDICT SPA / PRE.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PREDICT SPA (PRE.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRE.MI.


What is the valuation status for PRE stock?

ChartMill assigns a valuation rating of 2 / 10 to PREDICT SPA (PRE.MI). This can be considered as Overvalued.


What is the profitability of PRE stock?

PREDICT SPA (PRE.MI) has a profitability rating of 4 / 10.


Can you provide the financial health for PRE stock?

The financial health rating of PREDICT SPA (PRE.MI) is 7 / 10.